- Latest week
- 10 Jul 2026
- Close
- 3.180000
- Fair value
- 2.190671
- Next-week expectancy
- Undecided 51.66%
ESPR Chart Pack
Esperion Therapeutics Inc
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, ESPR rose 66.49%, moving from 1.91 to 3.18. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -5.18 and has improved across the 12-week window. Market Dynamics is 0.62 on the latest week. Next-week expectancy is undecided at 51.66% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 3.18
- 12-Week Change
- 66.49%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 51.66%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- -5.18
- Market Dynamics
- 0.62
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 3.18
- 12-Week Change
- 66.49%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 51.66%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- -5.18
- Market Dynamics
- 0.62
Over the latest 12 completed weeks ending 2026-07-10, ESPR rose 66.49%, moving from 1.91 to 3.18. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -5.18 and has improved across the 12-week window. Market Dynamics is 0.62 on the latest week. Next-week expectancy is undecided at 51.66% based on similar historical setup states.
Industry Peers
United States equities in Drug Manufacturers - Specialty & Generic
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| TLPH Talphera Inc. | NASDAQ | 10 Jul 2026 | 1.06 | 1.50 | 1.00 | 1.46 | 37.74% |
| AKBA Akebia Ther | NASDAQ | 10 Jul 2026 | 1.25 | 1.46 | 1.23 | 1.40 | 12.45% |
| ZYBT Zhengye Biotechnology Holding Limited Ordinary Shares | NASDAQ | 10 Jul 2026 | 0.69 | 0.82 | 0.63 | 0.78 | 12.43% |
| BCRX BioCryst Pharmaceuticals Inc | NASDAQ | 10 Jul 2026 | 9.80 | 11.22 | 9.71 | 10.45 | 6.63% |
| BFRI Biofrontera Inc | NASDAQ | 10 Jul 2026 | 1.04 | 1.21 | 1.03 | 1.10 | 5.77% |
| INM InMed Pharmaceuticals Inc | NASDAQ | 10 Jul 2026 | 1.56 | 1.70 | 1.56 | 1.64 | 5.13% |
| AYTU Aytu BioScience Inc | NASDAQ | 10 Jul 2026 | 2.16 | 2.30 | 2.15 | 2.25 | 4.17% |
| SNOA Sonoma Pharmaceuticals Inc | NASDAQ | 10 Jul 2026 | 1.21 | 1.31 | 1.19 | 1.26 | 4.13% |
| RMTI Rockwell Medical Inc | NASDAQ | 10 Jul 2026 | 5.43 | 6.14 | 5.39 | 5.61 | 3.31% |
| IRWD Ironwood Pharmaceuticals Inc | NASDAQ | 10 Jul 2026 | 4.33 | 4.88 | 4.27 | 4.47 | 3.23% |
| CABR Caring Brands, Inc. Common Stock | NASDAQ | 10 Jul 2026 | 1.30 | 1.52 | 1.30 | 1.34 | 3.08% |
| INDV Indivior PLC Ordinary Shares | NASDAQ | 10 Jul 2026 | 39.41 | 41.60 | 39.20 | 40.50 | 2.77% |
| ANIK Anika Therapeutics Inc | NASDAQ | 10 Jul 2026 | 15.30 | 16.49 | 14.93 | 15.60 | 1.96% |
| SUPN Supernus Pharmaceuticals Inc | NASDAQ | 10 Jul 2026 | 47.62 | 51.37 | 46.76 | 48.46 | 1.76% |
| XERS Xeris Pharmaceuticals Inc | NASDAQ | 10 Jul 2026 | 8.20 | 9.02 | 8.20 | 8.34 | 1.71% |
| CTOR Citius Oncology, Inc. | NASDAQ | 10 Jul 2026 | 0.68 | 0.74 | 0.67 | 0.69 | 1.47% |